SUMMARY Forty patients were treated for cardiogenic shock secondary to acute myocardial infarction. Twenty-one (group 1) were treated with intraaortic balloon counterpulsation and 19 (group 2) were treated with counterpulsation and coronary artery bypass grafting. The groups were similar in age, incidence of previous infarction, initial hemodynamics and coronary anatomy.
CARDIOGENIC SHOCK is currently the most common cause of death in patients hospitalized for acute myocardial infarction.'--Pathologic evidence suggests that power failure subsequent to myocardial infarction is associated with a critical loss of ventricular myocardium approximating 40% of left ventricular mass."
Moreover, it appears that in the setting of acute infarction, cardiogenic shock is an evolving event characterized by gradual impairment of functioning heart muscle.6' 7 Early results suggested that intraaortic balloon counterpulsation, although of temporary benefit in the management of cardiogenic shock, only marginally improved the long-term outlook for patients suffering from shock.8' 8 In contrast, recent data10' 1 suggest that early counterpulsation alone may offer favorable long-term results. On the other hand, early descriptions'2 of the combined use of balloon counterpulsation with surgery for cardiogenic shock indicated substantial reduction of mortality in patients treated early after shock developed.
It was unclear, therefore, whether comparable patient groups suffering from cardiogenic shock are best benefited by mechanical assist alone or in conjunction with emergency bypass grafting. Accordingly, we reviewed our results in the treatment of cardiogenic shock by intraaortic balloon counterpulsation with and without reperfusion.
From December 1973 to July 1978, 883 patients (ages 31-82 years) were admitted to the Sacred Heart and Deaconess Medical Centers with a diagnosis of acute transmural myocardial infarction characterized by 1) chest pain consistent with myocardial infarction, 2) persistent ST-segment elevation progressing to Q waves greater than 0.04 second by ECG, and 3) CK-MB isoenzyme elevation. The overall mortality for transmural infarction in this group was 17%.
Definition of Cardiogenic Shock
Forty patients were treated with intraaortic balloon counterpulsation for shock associated with acute myocardial infarction. Shock was defined as 1) central systolic arterial blood pressure less than 85 mm Hg (mean blood pressure less than 70 mm Hg), 2) functional volume expansion characterized by elevation of left ventricular filling pressure . 16-18 mm Hg, 3) clouded sensorium, 4) evidence of peripheral hypoperfusion on clinical exam (i.e., cold extremities with prolonged capillary filling time), 5) depressed urine flow, and 6) continued need for vasopressor support despite volume expansion. All criteria were necessary for inclusion. Abbreviations: Cl = cardiac index; LVFP = left ventricular filling pressure; EF = ejection fraction; SBP = central systolic blood pressure; IHM = in-hospital mortality; + = survivor;-= nonsurvivor.
1 were allocated to intraaortic balloon therapy alone because the physician initially managing the patient did not participate in the program involving acute revascularization presented elsewhere13 14 or because the patient declined therapy other than balloon pumping. Group 2 was evaluated angiographically with vasopressor support alone to eliminate the additional time required for insertion of the intraaortic balloon before angiography. The intraaortic balloon was inserted when the patient was in surgery as bypass grafting proceeded.
Exclusions
Patients with diffuse distal disease of the coronary arteries and those receiving mitral valve replacement were excluded from this study. There were no other exclusions; all patients with acute myocardial infarction and shock were included in the two groups.
Informed Consent
All patients gave informed consent. The advised consent form had been reviewed by the Human Ex- No 6, JUNE 1980 perimentation Committee of both hospitals. If the patient was unable to understand the nature of the interventions, family members were specifically informed that the procedures were not proved to decrease mortality and were experimental, but that the results might be of direct benefit to the patient.
Balloon Management
The AVCO and Datascope System 80 intraaortic balloom pumps were used equally in each group. A 30-ml or 40-ml intraaortic balloon was inserted through an end-to-side graft sewn to the femoral artery and advanced to the mouth of the left subclavian artery. The balloon was deflated automatically by the R wave of the ECG. In all cases, the balloon was timed to inflate at the dicrotic notch (as determined by radial or brachial arterial trace), thus ensuring maximal diastolic augmentation (counterpulsation) and appropriate timing of the balloon pump. During pumping, heparin boluses (4000 units i.v. every 4 hours) were used to maintain the partial thromboplastin time (PTT) 50-60 seconds (normally less than 35 seconds in our hospitals). PTT, arterial blood gases, hemoglobin and hematocrits were measured every 12 hours after each patient was stable. The PTT was monitored every 3 l/2hours until heparin therapy had been titrated to achieve the desired PTT. Low molecular weight dextran given intravenously at 10 ml/hour was used in addition to heparin therapy in two patients.
Weaning from counterpulsation was begun gradually, with each patient being "pumped" every other beat, then every third beat, and so on. If a patient became hemodynamically unstable (characterized by rising pulmonary capillary wedge pressure, falling cardiac output, decline in blood pressure) counterpulsation was resumed on a one-to-one basis. All patients received counterpulsation for Coronary anatomy was available in 19 of the 21 patients in group 1. In one case, permission for autopsy was not granted, and patient 20 refused angiography after hospitalization. Of the 19 patients with known anatomy, two were catheterized before infarction and eight within 6 weeks after infarction. Nine patients were examined at autopsy.
Two patients had left main disease (100% and 90% obstruction). Left main disease was counted as twovessel disease in this study. Five patients had threevessel disease and 13 had two-vessel disease. One had one-vessel obstruction (a large, dominant right coronary artery). All patients had proximal disease.
Coronary angiography and ventriculography were performed preoperatively in all group 2 patients, and each had proximal disease. Left main coronary artery involvement was present in two patients (100% and 80% obstruction). Three-vessel disease was present in five patients. Eleven patients had two-vessel disease, and three patients had one-vessel involvement (two patients had proximal right coronary artery occlusion associated with a diminutive left system).
Autopsy Study
The whole heart was removed from the chest in each case autopsied. The epicardial arteries were removed, decalcified and sectioned at 1-mm intervals. Each heart was weighed and the area of infarction was grossly identified. Because the measurement of interest was the presence or absence of hemorrhage, samples were taken from both infarcted and normal myocardium. After the junction of infarcted and normal myocardium was identified, multiple samples were taken. The area that included the junction of both normal and infarcted myocardium. was embedded in paraffin; serial sections were systematically examined and special attention was given to histologic features that might be consistent with extension of infarction into areas of normal myocardium.
Statistical Analysis
The t test (unpaired) was used for the analysis of continuous measurement variables and the chi-square test was used for discrete outcome variables.
Results

Comparability of Groups
The groups in this study are concurrent and appear to be comparable (table 5) in age, incidence of previous infarction, mean cardiac index, average initial systolic blood pressure, mean left ventricular filling pressure, the time interval from the onset of hypotension (the earliest marker of cardiogenic shock) to the institution of intraaortic balloon counterpulsation (mean 9.1 vs 6.0 hours) and the extent of coronary disease (2.2 vessels vs 2.1 vessels per patient). Although there were slightly more inferior infarctions in group 1, the incidence of proximal disease and the area of infarction by ECG were similar between groups. However, the time interval from the onset of infarction to hemodynamic instability was slightly longer in group 1 than in group 2.
Mortality Between Groups
The in-hospital mortality of the groups was not significantly different (42% vs 52.4%). Anterior wall involvement carried the greatest mortality in each group (62.5% in group 1 vs 47% in group 2). Inferior wall infarction was more benign in both groups (one death vs no deaths). The subset of group 2 treated within 16 hours from the onset of symptoms showed a 25% (three of 12) hospital mortality.
Three patients in group 1 died before weaning from counterpulsation was begun. No 18 hours after the onset of infarction had a 71.4% (five of seven) in-hospital mortality, while the patients treated within 16 hours had a 25% (three of 12) mortality rate. No patient was treated between 16 and 18 hours from the onset of infarction. Moreover, the only long-term death occurred in the group treated more than 18 hours after onset. The subset of group 2 treated within 16 hours after the onset of symptoms also had a significantly higher cardiac index (1.99 ± 0.42vs 1.77 ± 0.74, p < 0.05), but the mean left ventricular filling pressure, systolic arterial blood pressure, average age, area of infarction by ECG, incidence of previous infarction and the number of diseased vessels per patient were not significantly different. We do not know if the greater depression of cardiac index in the subset treated more than 18 hours after the onset of symptoms was a reflection of greater necrosis.
Of the 10 long-term survivors, four are in functional class I, five are in class I and one is in class III.
All patients (n = 4) autopsied in this group had gross hemorrhagic infarction ( fig. 1 ), but no apparent extension of injury into area of normal myocardium. The amount of myocardium damaged approached 50% in each instance. 
Discussion
This study demonstrates a striking reduction in mortality for patients operated on within 16 hours (25%) after the onset of infarction and subsequent shock. When grafting was performed more than 18 hours after the onset of symptoms, the mortality rate was disappointing (71.4%). The significance of this is unclear, but it may argue for a "critical period" for revascularization after which healing may be required, presumably accompanied by balloon support.
Groups 1 and 2 are concurrent as well as comparable in age, proximal coronary disease, incidence of multivessel disease, the incidence of previous infarction and hemodynamic measurements ( shock reported only slight improvement in the longterm mortality of patients treated with this modality alone. However, recent reports suggest that the longterm prognosis for patients with coronary shock treated with counterpulsation alone may be comparable to that for patients undergoing surgery and mechanical assistance.'2 Accordingly, this report was designed to investigate in concurrently treated groups whether counterpulsation alone applied in the early stage of coronary shock obviates the need for cardiac surgery.
Our results with intraaortic counterpulsation alone are comparable to those of other reported series8 9, [16] [17] [18] [19] and the outcome, in some respects, is more favorable.
These data confirm the reports of both Johnson 28 showed that augmentation of CK activity may be a "washout" phenomenon and not indicative of extension of necrosis after reperfusion. Recent investigation of the effects of reperfusion on infarct size did not identify extension of infarction when measured by 51Cr-labeled red blood cells. 29 We could not find evidence in favor of extension of infarction due to reperfusion, as all autopsy examinations indicated extensive infarction, but the hemorrhagic areas appeared to be confined to the area of necrosis. The unfavorable outcome of patients autopsied appeared to reflect the extent of underlying disease rather than aggravation of injury.
The precise role of infarctectomy as an adjunct to surgical revascularization is poorly defined. While Dunkman et al.12 used infarctectomy in a large portion of their series, infarctectomy was used in only one of our patients. It is unknown whether infarctectomy offers any advantage over reperfusion alone. If reperfusion hemorrhage is proved to be truly deleterious, infarctectomy may be helpful. On the other hand, the significance of reperfusion hemorrhage confined to the area of infarction is uncertain. Further, excision of large portions of ventricular myocardium from a severely damaged ventricle may leave the patient with insufficient myocardial mass to support an already failing circulation.
Clinical Implications
A controlled, randomized trial may be difficult in such high-risk groups. We recognized the problems of such a study and attempted to assess treatment of comparable, concurrent groups. Our results suggest that patients given immediate cardiac assistance with reperfusion have improved short and long-term survival if these procedures can be performed within 16 hours after the onset of infarction. 2 
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The use of inotropicl18 or vasodilating agents,20 sometimes used in combination,30 has not improved the long-term survival of these patients, possibly because of failure to appreciate the major determinants dictating the fate ofjeopardized myocardium. Further, the inability of intraaortic balloon counterpulsation alone to ensure long-term survival casts uncertainty on the value of this therapy without additional measures. These data suggest that early reperfusion and counterpulsation offer advantages over mechanical assist alone. Finally, without early, aggressive treatment, the prognosis for evolving corBresnahan and co-workers,'5 working with reper- 1 11 1 onary shock remains mostly unsatisfactory.
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